No-Spa (Drotaverine Hydrochloride)

Drotaverine Hydrochloride, the active ingredient in No-Spa, is an antispasmodic (phosphodiesterase inhibitor) presented as a tablet for oral use. It relieves smooth‑muscle spasm in the abdomen, biliary system, kidneys, uterus and urinary tract, primarily in adult patients. GNH USA supplies No-Spa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

No-Spa (drotaverine) acts on smooth‑muscle disorders, providing relief of spasm and associated pain. - Abdominal and gastrointestinal smooth muscle spasm: reduces pain and eases intestinal cramping. - Biliary colic: relaxes biliary ducts to alleviate gall‑bladder pain. - Renal colic: diminishes ureteral spasm, facilitating stone passage. - Menstrual cramps (dysmenorrhea): lessens uterine contractions and menstrual pain. - Urinary tract spasm: eases bladder neck and urethral spasm, improving comfort.

Adverse reactions may occur, ranging from mild to severe.

Common Side Effects: - Nausea: mild stomach upset. - Dizziness: transient light‑headedness. - Dry mouth: reduced salivation. - Headache: mild to moderate intensity. - Flushing: temporary skin redness. - Hypotension: mild blood‑pressure drop.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling. - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Severe hypotension: marked blood‑pressure fall requiring medical attention. - Cardiac arrhythmia: irregular heart rhythm. - Hepatic dysfunction: abnormal liver enzymes. - Hematologic abnormalities: rare blood‑cell changes.

Before using No‑Spa, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: use with caution; potential excretion in milk is unknown. - Renal impairment: dose adjustment may be required; monitor renal function. - Elderly patients: increased susceptibility to hypotension; start with lower dose if prescribed. - Concomitant medications: review all current drugs to avoid interactions. - Store at ambient temperature: keep in the original pack, protect from moisture.

Drotaverine may interact with several drug classes; monitoring is advised.

Major Interactions (Avoid): - Combined use with other potent antispasmodics: risk of excessive smooth‑muscle relaxation and hypotension. - Concurrent antihypertensives: additive blood‑pressure lowering effect. - MAO inhibitors: potential for unpredictable cardiovascular responses.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance dizziness and hypotensive effects. - Anticholinergic agents: increased dry‑mouth sensation. - CYP3A4 inhibitors (e.g., ketoconazole): possible increase in drotaverine plasma levels.